Instrument Inactif

Autres langues CEL-SCI Corporation Nyse

Actions

US1508375086

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CEL-SCI Appoints Mario Gobbo to Its Board of Directors	23/04
CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	23/04
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	19/03
CEL-SCI Corporation Issues Letter to Shareholders	06/03
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	15/02
Cel-Sci: Fiscal Q1 Earnings Snapshot	14/02
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	14/02
CEL-SCI Corporation (von First Berlin Equity Research GmbH...	14/02
Cel-Sci Closes $7.8 Million Share Offering	13/02
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	13/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	12/02
Health Care Slips on Rotation to High-Risk Sectors -- Health Care Roundup	10/02
Cel-Sci Prices $7.8 Million Public Offering of Common Shares	09/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	09/02
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head and Neck Cancer Drug	07/02
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06/02
CEL-SCI Corporation Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06/02
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path towards Marketing Authorization for Multikine	01/02
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon	31/01
Sector Update: Health Care Stocks Gain in Afternoon Trading	31/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CEL-SCI Corporation Nyse

Actions

US1508375086

Autres langues

Filtres